Human medicines European public assessment report (EPAR): Bydureon, exenatide, Date of authorisation: 17/06/2011, Revision: 27, Status: Withdrawn

Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 6, Status: Authorised

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 15 July 2026, 09:30 (CEST) to 15 July 2026, 13:30 (CEST)

Meeting summary - Medicine shortages SPOC working party meeting 15 July 2026

Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

Advice on ‘end-of-year’ submission dates for type I variations in 2026

EMA Management Board: highlights of September 2026 meeting

Proceedings for the nomination and appointment of the next EMA Executive Director